| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2003-10-02 |
4 |
AS |
$20.01 |
$80,040 |
D/D |
(4,000) |
215,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2003-12-02 |
4 |
AS |
$20.20 |
$80,800 |
D/D |
(4,000) |
214,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-02-09 |
4 |
AS |
$20.58 |
$82,300 |
D/D |
(4,000) |
210,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-03-02 |
4 |
AS |
$25.00 |
$150,000 |
D/D |
(6,000) |
204,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-05-10 |
4 |
AS |
$21.01 |
$84,040 |
D/D |
(4,000) |
200,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-08-23 |
4 |
OE |
$2.38 |
$69,272 |
D/D |
29,167 |
226,312 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-08-23 |
4 |
AS |
$15.55 |
$144,068 |
D/D |
(9,167) |
217,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-09-24 |
4 |
AS |
$17.45 |
$161,139 |
D/D |
(9,167) |
237,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-09-24 |
4 |
OE |
$2.38 |
$69,272 |
D/D |
29,167 |
246,312 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-10-22 |
4 |
AS |
$16.85 |
$288,687 |
D/D |
(17,000) |
249,312 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-10-22 |
4 |
OE |
$2.38 |
$69,272 |
D/D |
29,167 |
266,312 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-11-05 |
4 |
OE |
$2.38 |
$1,299 |
D/D |
547 |
249,859 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-11-05 |
4 |
AS |
$20.00 |
$3,980 |
D/D |
(199) |
249,660 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-11-08 |
4 |
OE |
$2.38 |
$31,951 |
D/D |
13,453 |
263,113 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-11-08 |
4 |
AS |
$19.94 |
$155,552 |
D/D |
(7,801) |
255,312 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-11-22 |
4 |
AS |
$20.20 |
$507,189 |
D/D |
(25,000) |
274,062 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-11-22 |
4 |
OE |
$2.38 |
$103,906 |
D/D |
43,750 |
299,062 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-12-17 |
4 |
OE |
$2.38 |
$24,740 |
D/D |
10,417 |
284,479 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-12-17 |
4 |
AS |
$25.01 |
$125,050 |
D/D |
(5,000) |
279,479 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-12-29 |
4 |
AS |
$25.03 |
$232,253 |
D/D |
(9,279) |
289,532 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2004-12-29 |
4 |
OE |
$2.38 |
$45,914 |
D/D |
19,332 |
298,811 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2005-01-18 |
4 |
AS |
$24.61 |
$58,744 |
D/D |
(2,387) |
287,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2005-02-01 |
4 |
AS |
$25.01 |
$125,075 |
D/D |
(5,000) |
282,145 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2005-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
11,250 |
293,395 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2005-08-01 |
4 |
OE |
$10.00 |
$160,930 |
D/D |
16,093 |
300,261 |
|
- |
|
283 Records found
|
|
Page 1 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
